TG Therapeutics | TGTX - Vermögenswerte





Vermögenswerte Veränderung Datum
AbbVie USD 135.12B 1.35B 2026-06
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Amgen USD 95.64B 3.14B 2026-06
Ardelyx USD 504.51M 2.9M 2026-03
Arrowhead Research USD 2.11B 156.25M 2026-06
Bayer EUR 107.29B 659M 2026-06
Biogen USD 32.09B 2.6B 2026-06
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Curis USD 29.69M 9.72M 2026-03
Gilead Sciences USD 49.36B 6.92B 2026-06
J&J USD 201.06B 167M 2026-06
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Novartis USD 122.03B 3.5B 2026-06
Novavax USD 955.58M 87.59M 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
TG Therapeutics USD 1.64B 110.79M 2026-06
Verastem USD 227.81M 18.63M 2026-03
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06